1.33 USD
-0.04 (-2.92%)
1.21 USD
-0.12 (-9.02%)
ChartMill assigns a Buy % Consensus number of 83% to SBFM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.12. This target is 360.15% above the current price.
SBFM was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SBFM.
In the previous month the buy percentage consensus was at a similar level.
SBFM was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-08 | Aegis Capital | Reiterate | Buy -> Buy |
| 2024-12-05 | Aegis Capital | Reiterate | Buy -> Buy |
| 2023-08-07 | Aegis Capital | Initiate | Buy |
SUNSHINE BIOPHARMA INC / SBFM FAQ
Can you provide the average price target for SUNSHINE BIOPHARMA INC stock?
7 analysts have analysed SBFM and the average price target is 6.12 USD. This implies a price increase of 360.15% is expected in the next year compared to the current price of 1.33.
How do analysts rate SUNSHINE BIOPHARMA INC (SBFM)?
The consensus rating for SUNSHINE BIOPHARMA INC (SBFM) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.